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Abstract
Bioprospecting is the process of discovery and commercialisation of new products from
natural resources.Today the development of new products by pharmaceutical and
bioindustries focuses on synthetic approaches; natural compounds are still the main
source of biomolecules with genuinely novel structural features and properties. More than
15,000 natural products have been discovered by scientists studying marine algae,
microbes, and invertebrates.Microalgae have adapted to compete for resources by a
number of means. They can produce and excrete secondary metabolites which positively
or negatively influence the growth, survival, and reproduction of predators, prey or
competitors. This process is known as allelopathy and microalgae that produce
allelochemicals may be a viable source of new future drugs in bioprospecting. The main
aims of this Masters thesis was to investigate if phytoplankton from Norwegian waters
produce secondary metabolites that could be of use in medicine and if these substances
have an eﬀect on other algae. Secondary aims are to discover if diﬀerent fractionated
extracts vary in their eﬀect and if nutrient conditions during culturing may have an
influence on the bioactivity of these extracts. High throughput screening of algal extracts
was carried out using two bioassays. The first a viability assay to test the inhibition of
growth and cytotoxicity of algal extracts on Jurkat cancer cells. The second is an
apoptosis assay designed to investigate the the ability of algal extracts to cause apoptosis,
again in Jurkat cells. Haptophyte Prymnesium polylepis was shown to have good
potential in the bioassays and was chosen for nutrient limited culturing and allelopathy
experiments. These experiments indicated that nutrient limitation can cause variability in
the degree of growth inhibition and apoptotic activity of Prymnesium polylepis.
Allelopathy of P. polylepis on the chain forming diatom Skeletonema pseudocostatum also
varied according to growth conditions. Overall, there is a potential for the discovery of
new future drugs from Norwegian microalgae and this study aims to give insight into
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Bioprospecting is the process of discovery and commercialisation of new products from
natural resources. Man has always used wildlife to his own end and today as many as two
thirds of commercial pharmaceuticals have their roots in nature (Cragg, Grothaus, and
Newman 2009). About 60% of the world’ÌĄs population relies almost entirely on plants
for medication (Farnsworth 1994). Since more than 70% of the earth’s surface is covered
by water and most of this is contained in the oceans, it is surprising how marine
bioprospecting is not as well known as its terrestrial counterpart. The sea provides a
barrier to exploration that is harder to overcome than obstacles experienced on terra
firma. Nevertheless, even early examples do exist. The Chinese are credited with the first
use of cyanobacteria Nostoc during times of famine over 2000 years ago Jensen, Ginsberg,
and Drapeau 2001. Arthrospira (Spirulina) and Aphanizomenon species have also a
history of being used as a food source in times of need. The first large-scale use of
microalgae in a commercial setting began more than 60 years ago in Asia (Borowitzka
1999). The majority of eﬀort was put into growing algal biomass as a food source but
some investigation also occurred into secondary metabolites with antimicrobial, antiviral,
and anticancer activity as well as those that aﬀected processes and pathways in the cell,
aiding to the understanding of cell function (Borowitzka 1995).
Today the development of new products by pharmaceutical and bioindustries focuses on
synthetic approaches; natural compounds are still the main source of biomolecules with
genuinely novel structural features and properties (Harvey et al. 2010). More than 15,000
natural products have been discovered by scientists studying marine algae, microbes, and
invertebrates (Salomon, Magarvey, and Sherman 2004). Whereas before bioprospecting
focused on terrestrial sources, the rate of discovery of new metabolites from land based
sources is decreasing and new leads are needed. Also, as infectious diseases evolve and
develop resistance to existing pharmaceuticals, the marine environment can provide new
means to treat fungal, parasitic, bacterial and viral disease. With 34 out of 36 phyla of
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life present, the oceans harbour the greatest biodiversity on earth (Donia and Hamann
2003). It is no surprise that research into algae and marine animals such as ascidians,
bryozoans, molluscs, soft corals, and sponges has shown that the marine environment can
yield unique secondary metabolites not yet found terrestrially (Faulkner 1996; Attaway
and Zaborsky 2013).
Chlorophyte alga Dunaliella salina is cultured for Îš-carotene, which has a multitude of
uses including vitamin supplements, antioxidants, and a source of pigmentation for farmed
prawns (Borowitzka 1999). D. salina can be made to overproduce and store Îš-carotene
under stressful conditions such as high light intensity or nutrient starvation (Emeish
2012). Îš-carotene from Dunaliella is now being produced on a commercial scale in
Australia, the USA and Israel. Secondary metabolites isolated from marine cyanobacteria
found to target tubulin and actin filaments in eukaryotic cells (Jordan 1998) have been
earmarked as potential anticancer drugs. In another study, half of the 41 cyanobacterial
strains screened induced apoptosis in cancer cells (Oftedal et al. 2010). Extracts from one
of these were shown to work in tandem with existing cancer drugs to kill leukemia cells
without having negative eﬀects on healthy cardiomyocytes (heart muscle cells).
Many bioprospecting undertakings have hit a wall after the discovery of a compound of
interest. If the organism responsible cannot be grown in the lab, repeated excursions into
the field are necessary to collect more material. Clinical trials on anticancer agent
bryostatin-1 required the collection of approximately 12.6 metric tons of bryozoans to give
an 18g sample (Schaufelberger et al. 1991). Approved anti-tumor agent ecteinascidin 743
had its development delayed by two decades because of diﬃculties in collecting enough
tunicates needed to prepare the final elucidation (Molinski et al. 2009). It is for these
reasons that easily cultured organisms like microalgae may be more suitable as a source
for bioprospecting.
1.2 Allelopathy
Microalgae have adapted to compete for resources by a number of means. Changes in
surface to volume ratio, production of specific enzymes, variations in nutrient
requirements, luxury uptake of macronutrients and trace elements, pigment composition,
photosynthetic capacity, mixotrophy, and vertical migration are all used to gain a
competitive edge. Phytoplankton are also known to produce secondary metabolites that
directly aﬀect other organisms. Known as allelochemicals, these substances can positively
or negatively influence the growth, survival, and reproduction of predators, prey or
competitors. Allelopathy in the oceans is mediated by physical (viscosity, shear forces, low
2
reynolds numbers) as well as chemical (dilution) factors that have put a selective strain on
the algae (Legrand et al. 2003). Allelochemicals are rapidly diluted once released into
water and so need to be potent to have an eﬀect. Due to the dynamic nature of the ocean
they must work over a short time scale to be of benefit. In the lab, several secondary
metabolites produced by phytoplankton have been shown to aﬀect other algae as well as
bacteria, fungi and viruses (Legrand et al. 2003). Studies in the field have also shown that
allelopathy can influence population dynamics in microalgae (Keating 1977; Pratt 1966;
Rojo et al. 2000). These unicellular organisms can aﬀect access to light and nutrients,
grazing, or hydrodynamics (Verity and Smetacek 1996). Toxic blooms are among the
most studies allelopathic interactions due to their ecological and economical impact.
During summer 1988, a bloom of haptophyte Prymnesium polylepis (=Chrysochromulina
polylepis) occurred over an area of 75,000 km2 oﬀ the Scandinavian coastline. This bloom
was toxic and caused widespread damage of both farmed fish and native species
(Rosenberg, Lindahl, and Blanck 1988; Dahl et al. 1989; Underdal et al. 1989; Nielsen
1990; Kaas et al. 1991; Robertson 1991). P. polylepis was originally described as non-toxic
to fish and not known to occur in the density observed in 1988 (Manton and Parke 1962).
Extensive research was carried out to understand the conditions that lead to such an
extraordinary event. The Norwegian Fisheries Research Council began the Harmful Algae
program and research began into the eﬀect of pH, temperature, nutrient concentration,
light intensity, salinity, growth phase, and life cycle stage on toxin production in
Prymnesium polylepis and closely related species. Out of this list, nutrient conditions
seemed to be most influential factor with significantly higher hemolytic activity regardless
if N or P is the limiting nutrient (N. Johansson and E. Granéli 1999). A change in pH
from 8 to 9 was also found to increase toxicity of P. polylepis against Heterocapsa
triquetra four fold and was deemed to be more influential than growth phase (Schmidt
and Hansen 2001). It was determined that low levels of phosphorous at the end of the
1988 bloom may have contributed to its abnormal toxicity (Dahl et al. 1989; Maestrini
and E Granéli 1991; Skjoldal and Dundas 1991; Edvardsen and Paasche 1998).
In 1989 another toxic bloom, this time of Prymnesium parvum, killed 750 metric tons of
farmed salmon and trout in a fjord system in Ryfylke, W Norway (Kaartvedt et al. 1991).
Blooms in subsequent years caused more economical damage but lessened in economical
damage over time as fish farms closed. P. parvum occurs worldwide in temperate brackish
waters (Edvardsen and Paasche 1998; Lundholm and Moestrup 2006) but had not caused
a mass fish kill of this magnitude before in marine waters. The ichthytoxic eﬀects in this
species were assumed to be caused by prymnesium-1 and prymnesium-2, deemed highly
toxic by (Igarashi Shiro|Yasumoto,Takeshi 1998). Prymnesins are harmful due to their
ability to increase cell membrane permeability and disturb the balance of ions in cells. On
contact with fish, these toxins can block the gill cells ability to absorb oxygen and cause
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death. The wider marine community is also aﬀected by prymnesins including; other algae
(Arlstad 1991), copepods (Nejstgaard and Solberg 1996), as well as bacteria and ciliates
(Fistarol, Legrand, and Edna Granéli 2003). If these microalgae, common in Norwegian
waters and previously thought to be harmless, could have such a large allelopathic aﬀect
when exposed to particular conditions then there is scope for similar discoveries with
other related species. It is this possibility that my project was based on.
1.3 Aims of this study
The algal culture collection used during this study is housed at the Section for Aquatic
Biology and Toxicology, Department of Biosciences, University of Oslo. It contains over
230 algal strains isolated from diﬀerent water masses around the world; some are more
than 50 years old. Many of these are from Norwegian marine waters. These algae were
the tools with which the main questions for this project would be answered. The first of
these questions was which strains from the library show bioactivity with high throughput
screening. Some algae selected from the library were chosen because they represented
diﬀerent major algal lineages. Some had shown previous toxic or allelopathic activity (like
haptophytes Prymnesium parvum and polylepis) while others had not. The main aim was
to screen as many strains as possible for growth inhibition and apoptosis against cancer
cells. In addition, harvesting was carried out at two diﬀerent time points for each strain
to see if growth phase caused variation in bioactivity.
After harvesting, fractionated extraction was carried out using diﬀerent solvents. This was
designed to answer the second question posed in this project; which extracted fractions of
the selected strains have highest bioactivity? As the initial screening was general in
nature, it made sense to obtain as many fractions as possible in the hope of discovering
bioactive compounds. Each extract was then tested in the bioassay to determine if the
solvents used in its extraction gave a better result.
Once the first round of screening was completed and results were analysed, the next
question could be addressed; how do culturing conditions (e.g. temperature, salinity, light,
or nutrients) aﬀect bioactivity. Changing environmental conditions can cause a previously
benign alga to become toxic. For this study, it was decided that, based on previous
research on toxic haptophytes nutrient limitation was most likely to cause a change in
bioactivity. After bioactive strains were grown under nutrient limited conditions they
could be used to help answer the final question; do strains have allelopathic eﬀects on
other microalgae? This can be tested in various ways such as growing donor and target
algae together or cross culturing growing target algae in medium previously used to
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culture the donor species, e.g. by adding filtrate from the donor culture to target cultures,
which was used in this Masters thesis. This question was expanded upon by investigating
if changing nutrient conditions, life cycle stage of a strain, or the method of removing live
cells from donor culture preparation (filtration or lysis) could cause variability on the




2.1 High throughput screening of algae for bioactivity
The basis of this experiment was to grow Norwegian microalgae in batch cultures under
good conditions (suﬃcient light and nutrients, suitable temperature and salinity), harvest
half of the cultures during the exponential growth phase and the remainder during
stationary. Solvent extractions were carried out to isolate compounds of diﬀerent polarity,
which were tested against Jurkat cells (human cancer cell line) to gauge a response. The
objective was to see if any of the strains gave an initial response under good growth
conditions so they could be chosen to continue with further experimentation. A secondary
objective was to assess any variation in isolates from cultures harvested during exponential
or stationary phases (i.e. as conditions become less ideal and cells may be stressed).
2.1.1 Culturing Algae for High Throughput Screening
Microalgae for this project were obtained from the UiO culture collection maintained at
the Section for Aquatic Biology and Toxicology, Department of Biosciences, UiO Blindern.
All strains used originated form Norwegian waters. Some of the species have been
associated with fish kills in nature (Prymnesium spp. and Karlodinium micrum ) and are
known to have allelopathic eﬀects on other organisms, but none have been previously
tested for eﬀects on Jurkat cells. A summary s given in Table 2.1 below.
7
Table 2.1: Summary of strains included in this study. Strain code is as registered in the UiO algal culture collection of University of Oslo.
Temperature was measured in degrees celsius and salinity in practical salinity units (PSU).
Strain code Species Division Origin Salinity Temperature
UIO 004 Micromonas pusilla Prasinophyta Skagerrak 25 16
UIO 007 Pseudoscourfieldia marina Prasinophyta Oslofjorden 25 19
UIO 015 Synecococcus sp. Cyanobacteria Raunefjorden 25 19
UIO 018 Phormidium sp. Cyanobacteria Oslofjorden 25 16
UIO 040 Prymnesium polylepis Haptophyta Risor 30 19
UIO 054 Prymnesium parvum Haptophyta Ryfylke 30 19
UIO 063 Brachiomonas submarina Chlorophyta Raunefjorden 22 19
UIO 226 Dunaliella tertiolecta Chlorophyta Oslofjorden 22 19
UIO 254 Karlodinium micrum Dinophyta Oslofjorden 30 19
UIO 305 Becheleria cincta Dinophyta Flekkefjord 30 19
K 0026 Eutreptiella braarudii Euglenophyta Norway 25 38
10mL of each strain was inoculated in cell culture flasks (50 mL, Nalgene) with 30ml
IMR 1/2 medium (modified version by E. Paasche of that described in Eppley et al. 1967,
protocol in Appendix A). These cultures were grown in conditions as in Table 2.1 until
dense enough to be used as inoculum to 1 L Erlenmeyer flasks with 900 mL IMR 1/2
medium. Density was calculated before inoculation and is summarised in Table 2.2.
Table 2.2: Cell density of cultures before inoculation. When cell concentration could not be
estimated accurately with the haemocytometer (cells clumped together, very low density), ND is
used. Minimum 400 cells were counted per culture.
Strain code Species Cells/mL
UIO 004 Micromonas pusilla ND
UIO 007 Pseudoscourfieldia marina 1920000
UIO 015 Synecococcus sp. ND
UIO 018 Phormidium sp. ND
UIO 040 Prymnesium polylepis 112500
UIO 054 Prymnesium parvum 313000
UIO 063 Brachiomonas submarina 74000
UIO 226 Dunaliella tertiolecta 178000
UIO 254 Karlodinium micrum 34000
UIO 305 Becheleria cincta 85000
K 0026 Eutreptiella braarudii 2500
Each algal strain was cultured with 4 1L replicates, two for harvest during exponential
phase and two during stationary. Cultures were then placed in a culture room of ideal
temperature. Light intensity was measured using Biospherical Instruments QSL-100 and
cultures were placed to give ca. 100 Îĳmol photons m-2 s-1 and given a day night cycle of
14 h of light and 10 h dark. A 3mL sample from each inoculum was fixed with LugolâĂŹs
solution (1%) final concentration) and initial cell concentration was determined using a
light microscope and Fuchs Rosenthal haemocytometer. A minimum of 400 cells was
counted, giving a confidence level of 95% with a +/- 10% margin of error.
10 mL of inoculum was added to the 1 L cultures, and equal amount to all 4 replicate
cultures. Even though this lead to cultures having diﬀerent starting densities, it was
decided that this method was a good compromise. After 2-4 days growth (depending on
strain), three 1ml samples of each replicate culture were pipetted into 48 well Falcon
Tissue Culture Plates(Thermo Sceintific) and in vivo fluorescence was measured at 460nm
with a BioTek Instruments Synergy MX plate reader. Subsequent readings were then
taken at the same time of day every 48 hours (Monday, Wednesday and Friday, not on
weekends). Fluorescence was used as an estimate of cell density and was graphed in excel
to indicate growth phase stage. Two cultures were harvested when they reached the
exponential phase and the remaining two during stationary phase. Before harvest 3ml
subsamples of each culture were taken and fixed with Lugol’s solution (1% final
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concentration) and final cell density was determined using microscope and
haemocytometer.
Cultures were harvested by vacuum filtration using 55mm Whatman GF/F glass fibre
filters. Filtrate and filters were frozen at -20°C after harvesting and transported to the
Department of Pharmacy, UiO for chemical extraction and fractionation.
2.1.2 Data analysis and graphing
Data from the plate reader was first formatted in Microsoft Excel and then exported to R
for analysis and graphing. The mean, standard deviation and standard error were
calculated for each culture from the three replicate measurements. Growth curves were
made by plotting time (in days) against fluorescence (relative units). Max growth was
calculated from the points making up the steepest part of these curves (exponential
phase). K (divisions/day) is equivalent to the slope of each curve and this was calculated
by linear regression. These graphs are presented later in section 3.1.1.
2.1.3 Chemical extractions and fractionation
A Dionex Accelereated Solvent Extraction machine (ASE 350) from Thermo Scientific was
used for all extractions. Due to the large volume of material on the GF/F filters, 66mL
stainless steel cells were used. A 30mm ASE extraction filter was placed in the bottom of
each cell and then half filled with Dionex ASE prep diatomaceous earth. GF/F filters
with harvested algal material were cut into small pieces and then placed in the cells. Each
cell was topped oﬀ with diatomaceous earth, sealed and loaded in the ASE. Extraction
was carried out using hexane, ethyl acetate, ethanol and water. Temperature for addition
of organic solvents was set at 40°C and water at 100°C. After extraction, organic solvent
fractions were left to dry by evaporation in a fume hood and those with water as a solvent
were freeze-dried.
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Figure 2.1: Flow chart for ASE chemical extraction and fractionation of algal material.
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2.1.4 Screening for bioactivity
After extraction the fractions underwent high throughput screening at the Department of
Biotechnology (person responsible Anne Jorunn Stokke). Extracts were added to 100%
DMSO to obtain 10mg extract/mL DMSO and left overnight to dissolve fully.
First fractionated extracts underwent Cell Titer Glo viability assay (Promega). The
DMSO-extract solution was added to 384 well Echo source plates (Labcyte) and stored at
room temperature in an argon atmosphere until needed. An Echo 550 liquid handler
(Labcyte) was used to transfer extracts to 384 well assay plates (Cellstar). Concentration
was varied in a dilution series (100-12.5nL). Jurkat cells (LGC Standards GmbH) were
seeded into assay plates (20µL, 1500 cells/well) and assays were incubated for 48 hours at
37°C (5% CO2, >95% humidity). Cell viability was then detected using Cell Titer Glo kit
(Promega). 20 ÂțL CTG Reagent was added to each well, plates were mixed for 1 minute
on a linear shaker (Envision) and incubated in the dark for 10 minutes at room
temperature. The reagent lyses cells and luminesces proportional to the amount of ATP
present. An Envision 2102 multilabel reader was used to read luminescence and raw data
was then transferred to Excel for analysis.
A Caspase-Glo apoptosis assay (Promega) was used to investigate apoptosis caused by the
algal fractionated extracts. Extracts were added to 384 well assay plates (Cellstar) using
an Echo 550 liquid handler (Labcyte). Concentration of extracts was at 50 and
100Âțg/mL. Jurkat cells were seeded into assay plates (20 Îĳl, 1500 cells/well), a time=0
reading was taken and then plates were incubated for 1, 2, 6, and 24 hours respectively
(37°C (5% CO2, >95% humidity). 20µL Caspase Glo reagent was added to each well and
plates were mixed for 30 seconds on a linear shaker. After 30 minutes incubation time
luminescence was read using an Envision 2102 multilabel reader. Luminescence is
proportional to the level of caspase 3/7 activity which is an essential part of apoptosis
(programmed cell death). Raw data was then transferred to Excel for analysis.
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2.2 Culture experiment with varying nutrients
Extracts of a strain of the haptophyte Prymnesium polylepis, strain UIO 040 showed clear
activity in the bioassays and was chosen for a second round of experiments to investigate
the eﬀect of varying nutrient growth conditions on allelopathy, namely the growth of
another phytoplankton species. As the UiO algal culture collection has multiple strains of
P. polylepis, it was also decided to test both its authentic and alternate life cycle stages to
see if these would have diﬀerent allelopatic eﬀects or not.
2.2.1 Examination in the transmission electron microscope
Whole mount electron microscopy preparations of the strains UIO 036, 037, 039 and 040
of Prymnesium polylepis were made (as described by Wenche Eikrem 1996). A droplet of
each culture was placed on carbon coated copper grids, fixed with osmic acid (2% vapour)
and stained with uranyl acetate (saturated solution). The grids were viewed by
transmission electron microscopy (TEM) (Philips CM150 at the Electron Microscopy
Laboratory for Biosciences, Department of Biosciences, University of Oslo). According to
the scale types observed, it was determined that strain UIO 037 was in alternate life cycle
stage and UIO 040 authentic (see Edvardsen and Paasche 1992) and so they were chosen
to be part of the experiment.
2.2.2 Culturing algae with varying nutrient conditions
50mL cell culture flasks with 25PSU IMR 1/2 algal medium (according to protocol in
Appendix A) were inoculated with strains UIO 037 and UIO 040 one week prior to
beginning the experiment. Inoculum cultures were then transferred to 1L Erlenmeyer
flasks with 2 replicates and four nutrient conditions (8 flasks total per strain). Flasks were
filled with 900mL of medium and inoculated with 10mL of inoculum culture. Light was
kept at ca. 100µmol photons m 2 s 1 (measured with Biospherical Instruments QSL-100)
and a day:night cycle (14:10 h L:D). Temperature was at a constant 19°C. Phosphate and
nitrate were added to obtain the nutrient concentrations listed below.
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Table 2.3: Nutrient conditions for each strain used in the experiment
Treatment Amount added (µL/L) Final Concentration (µM)
PO 43  NO3  PO 43  NO3 
+P +N 500 500 25 250
-P -N 0 0 2 25
-P +N 0 500 2 250
+P -N 500 0 25 25
Before inoculation 3mL subsamples of each culture were taken and fixed with Lugol’s
solution (1% final concentration). Cell density of each was determined using a
haemocytometer and light microscope. The cell concentration in the inoculum was ca.
4x105 cells/mL (minimum counted cells (n)= 400).
Cell density was measured immediately after inoculation and then every two days by in
vivo fluorescence in a plate reader (3 subsamples in 46 well plates, 460nm). Cultures were
grown until a marked diﬀerence in cell density was observed for each nutrient condition
(stationary phase after 8 days). Harvesting was carried out by vacuum filtration using
55mm Whatman GF/F filters. 10mL of each was transferred to cell culture flasks and
kept in culture for the allelopathy stage of the experiment. The filters were frozen at
-20°C until ASE extraction at Dept. Pharmacy was carried out (as in part 2.1.2).
Screening for bioactivity was also carried out at Dept. of Biotechnology (as in 2.1.3).
2.2.3 Allelopathy experiment
10mL subsamples of each flask were taken before harvest and pooled according to
replicates in 30mL glass vials (giving 8 vials total). 8mL of this was placed in an
ultrasonic bath for 3 minutes to lyse cells (checked with inverted microscope to ensure no
living (motile) cells remained). The remaining 12mL was preserved with Lugol’s (1% final
concentration) and cell density was determined with haemocytometer and microscope.
10mL filtrate from each replicate was taken during harvesting and pooled in 30ml glass
vials according to replicates to give 8x 20mL samples.
A dilution series was set up after a log2 scale for each of the 16 vials. Four mL was
pipetted from each vial to glass centrifuge tubes with 4mL cold 25 PSU IMR 1/2 medium
(50% dilution of original). This was mixed well by pipetting and 4mL was taken and
added to a new tube with 4mL medium and mixed well (25% dilution). This was
repeated twice more to give 12.5 and 6.25% dilutions. The resulting series was as follows
100% (original filtrate/lysed cells), 50%, 25%, 12,5%, 6.25% of original solution.
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The target organism for the allelopathy experiment was Skeletonema pseudocostatum
(strain NIVA BAC1, Bacillariophyceae). Cultures were grown in 50mL cell culture flasks
at 19°C in 30mL IMR 1/2 medium (34 PSU with added silicate and HCL to buﬀer to pH
8). These cultures were then diluted to 2000 cells/mL and 160µL was added to each well
in 4x 96 well Nunclon plates and placed in experimental conditions (17°C, 100µmol
photons m 2 s 1 light, day:night cycle of 14:10 h L:D) 24 hours before addition of the P.
polylepis extracts. 160µL of the 5 concentrations plus a control of 100% IMR 1/2 at 25
PSU were added in replicates of four to plates according to the figure below. All work was
carried out in a cold sterile room at ca. 15°C to avoid unwanted eﬀects on the
Skeletonema due to changes in temperature.
A total of four plates were used (UIO 037 filtrate, UIO 037 lysed cells, UIO 040 filtrate,
UIO 040 lysed cells). Cell density was determined using in vivo fluorescence and plates
were placed in 17°C culture room with 100µmol photons m 2 s 1 light at a 14:10 L:D
cycle. Fluorescence was measured at the same time daily (11am) for 7 days with the plate
reader.
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2.2.4 Analysis and statistics
Data from the plate reader was first formatted in excel and then exported to R for
analysis and graphing. For the nutrient experiment mean, standard deviation and
standard error were calculated for both cultures from the three replicate measurements.
Growth curves were made by plotting time (days) against fluorescence (relative units).
These were used to track growth during the experiment and are presented in Appendix C.
Nonlinear mixed eﬀect modelling (nlme package, Pinheiro and Bates 2000) was used to
investigate the eﬀect of each treatment on the growth of Skeletonema during the
allelopathy experiment. The data was grouped using the groupedData function and start
points were given with nlsList and SSlogis. The data was plugged into the nlme model
and eﬀorts were made to simplify it as much as possible according to methods.
Confidence interval plots were drawn to assess the variation in each factor (Asym, scal,
and xmid). The ratio of standard deviation in random eﬀects from their fixed
counterparts was also calculated for the same reason. If a random factor was not varying
between groups (treatments), then the model was updated to run without it. The
simplified model was then tested against the original with ANOVA and AIC tests. If the
AIC and p values were lower for the newer model then it was chosen for use, otherwise the
more complex model was used. These steps were repeated so that Asym, scal and xmid
were tested individually for each dataset until the least complex model was found for each
(usually the scal eﬀects were removed). The results form the model fit were plotted and
are presented later in section 3.2.2.
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Results
3.1 High throughput screening for bioactivity
Eleven strains in total were screened of haptophytes, dinoflagellates, chlorophytes,
cryptophytes, cyanobacteria, and euglenophytes from the UiO algal culture collection.
Timing harvesting was important as the potency of extracts may change depending on
growth phase stage. To determine when to harvest, cell density was measured regularly by
in vivo fluorescence. Fluorescence (relative units) was plotted against time (days) to
generate a growth curve in R. The fluorescence values measured are shown in Appwndix
B.
3.1.1 Max growth rate curves
Once harvesting was complete, maximum growth rates were calculated for each strain
where possible (minimum of three readings were needed within the exponential phase).
The mean for each reading was calculated along with its standard error. Linear regression
was then carried out and a line of best fit drawn. The slope of this line is equivalent to
growth rate (k), the amount of divisions per day.
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Figure 3.1: In vivo fluorescence of; a) Pseudoscourfieldia marina, b) Eutreptiella braarudii, c)
Prymnesium polylepis, and d) Prymnesium parvum as measured by the plate reader. Each point
is the mean of 3 subsamples, standard error is shown with black error bars. Linear regression was
carried out and is shown as the black line of best fit. Prymnesium parvum flask one and two
were harvested before the exponential phase had ended and so only data from the two stationary
phase cultures are included. Note diﬀerent scales on the both axes.
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Figure 3.2: In vivo fluorescence of; a) Brachimonas submarina, b) Karlodinium veneficum, c)
Biecheleria cincta, and d) Dunaliella tertiolecta as measured by the plate reader. Each point is
the mean of 3 subsamples. Standard error is shown with black error bars. Linear regression was
carried out and is shown as the black line of best fit. Karlodinium veneficum and Dunaliella
tertiolecta exponential cultures were harvested before the exponential phase had ended and so
only data from the two stationary phase cultures are included. Note diﬀerent scales on the both
axes.
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3.1.2 Viability and apoptosis assays
The results from the Cell Titer Glo (viability) and Caspase Glo (apoptosis) assays are
summarised in the figures below. Apoptosis assay plots show caspase 3/7 activity read as
luminescence after 1, 2, 6, or 22 hours incubation at concentrations of 50 and 100µg/ml.
Higher levels of caspase 3/7 activity at shorter incubation times indicate that an extract
may be of interest, as too are higher responses at lower concentrations.
Viability was assessed at five diﬀerent extract doses; 100, 50, 16.3, 5, and 1.25µg/ml. The
log of these concentrations was plotted against the percentage of growth inhibition (ATP
concentration after 48h incubation period). These curves were then fit against a 4
parameter logistic nonlinear regression model to estimate the half maximal inhibitory
concentration (IC50). If the data fit the model well, IC50 was given based on the inflection
point of the curve (C-parameter). IC50 is measured in µg/ml and so lower values mean
higher bioactivity and the extract can be considered more potent.
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Figure 3.3: Assay results from UIO 040 Prymnesium polylepis stationary phase, ethyl acetate
and hexane extractions. The apoptosis response curve (left) shows caspase activity read for
two concentrations at each time point. The viability dose response curves (right) show growth
inhibition (positive % growth) and cytotoxicity (negative % growth). IC50 is the point at which
the curve crosses zero on the y-axis (mg/mL).
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Figure 3.4: Assay results from UIO 004 Micromonas pusilla (stationary phase), UIO 226
Dunaliella tertiolecta (exponential phase), and UIO 305 Biecheleria cincta (stationary phase)
ethyl acetate extractions. The apoptosis response curve (left) shows caspase activity read for
two concentrations at each time point. The viability dose response curves (right) show growth
inhibition (positive % growth) and cytotoxicity (negative % growth). IC50 is the point at which
the curve crosses zero on the y-axis (mg/mL).
22
3.2 Nutrient experiments
3.2.1 Nutrient experiment growth curves
Prymnesium polylepis was chosen for nutrient and allelopathy experiments based on the
bioassay results. Previous research has shown that toxicity of P. polylepis can vary
between authentic and alternate life cycle stages and so it was necessary to determine
which life cycle stage each of the four strains in the UiO culture collection was in. Whole
mounts of UIO 036, 037, 039, and 040 were prepared for examination by TEM and it was
determined that UIO 037 was alternate and UIO 040 authentic cell type. Both of these
strains were grown under four diﬀerent nutrient treatments (+P+N, -P-N, -P+N, +P-N)
to assess if these conditions had any eﬀect on bioassay screenings and later allelopathy
experiments.
Growth curves below were generated in R from in vivo fluorescence data taken by the
plate reader during the nutrient limited or depleted culturing of the two P. polylepis
strains. Due to an unexpected growth spurt, readings only began during the later stage of
the exponential phase. Despite this, the plots show a clear diﬀerence between the four
treatments. The cultures with full nutrient levels reached highest cell density. The
cultures that obtained the next highest density were those with added nitrate, but no
phosphate. It could be these cultures still managed to grow relatively well as microalgae
have the ability store phosphorus or use bacteria as a source and these cultures were
non-axenic Nygaard and Tobiesen 1993 . Both strains with treatments -P-N and +P-N
grew to similar density, showing that nitrate limitation was more of an inhibiting factor
than phosphate.
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Figure 3.5: Plots showing in vivo fluorescence measurements over time illustrating the growth
of a) UIO 037, and b) UIO 040 as cultured under diﬀerent nutrient conditions. Each point is the
mean of three sub samples and the standard error is shown in black error bars.
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3.3 Bioassays of nutrient experiment
Apoptosis and viability assays for the nutrient experiment were carried out in much the
same way as the first round. Viability was estimated by measuring ATP concentration in
Jurkat cells after incubation with extracts for 48 hours. Caspase 5/7 activity was used to
estimate apoptosis in Jurkat cells at 50 and 100µg/mL doses after 1, 2, 6, and 24 hours
incubation time. Alternate strain UIO 037 showed more activity than UIO 040 with only
one UIO 040 viability assay fitting the 4PL model well and getting an IC50 value. Hexane






Figure 3.6: Assay results from UIO 037 Prymnesium polylepis +P+N, a) hexane and b) ethyl
acetate extractions. The apoptosis response curve (left) shows caspase activity read for two
concentrations at each time point. The viability dose response curves (right) show growth
inhibition (positive % growth) and cytotoxicity (negative % growth). IC50 is the point at which
the curve crosses zero on the y-axis (mg/mL).
26
cIC50	  =	  0.02772
Figure 3.7: Assay results from UIO 037 Prymnesium polylepis -P-N, hexane extraction (ethyl
acetate did not cause enough activity to obtain IC50 value). The apoptosis response curve (left)
shows caspase activity read for two concentrations at each time point. The viability dose response
curves (right) show growth inhibition (positive % growth) and cytotoxicity (negative % growth).





Figure 3.8: Assay results from UIO 037 Prymnesium polylepis -P+N, d) hexane and e) ethyl
acetate extractions. The apoptosis response curve (left) shows caspase activity read for two
concentrations at each time point. The viability dose response curves (right) show growth
inhibition (positive % growth) and cytotoxicity (negative % growth). IC50 is the point at which





Figure 3.9: Assay results from UIO 037 Prymnesium polylepis -P-N, f) hexane and g) ethyl
acetate extractions. The apoptosis response curve (left) shows caspase activity read for two
concentrations at each time point. The viability dose response curves (right) show growth
inhibition (positive % growth) and cytotoxicity (negative % growth). IC50 is the point at which
the curve crosses zero on the y-axis (mg/mL).
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hIC50	  =	  0.01928
Figure 3.10: Assay results from UIO 040 Prymnesium polylepis +P-N, ethyl acetate extraction
(hexane did not cause enough activity to obtain IC50 value). The apoptosis response curve (left)
shows caspase activity read for two concentrations at each time point. The viability dose response
curves (right) show growth inhibition (positive % growth) and cytotoxicity (negative % growth).
IC50 is the point at which the curve crosses zero on the y-axis (mg/mL).
UIO 040 did not show enough activity in the viability assay with ethyl acetate extracts
from the +P+N treatment being the only ones to fit the 4PL model and get a IC50 value.
At 0.01928µg/mL it is lower than any IC50 values from UIO 037 in this round of tests and
from any algae in the first screen (figures 3.3 and 3.4). Apoptosis for this extract was
lower than in previous tests (peak of 315 now versus 370 as shown in figure 3.3) and both
doses caused a similar response whereas before the 50µg/mL dose caused a higher level of
cell death. Except for the -P-N ethyl acetate extraction, all nutrient treatments and
extraction methods for UIO 037 caused enough variation in the viability assay to fit the
model and gain IC50 values. The lowest IC50 was for the hexane extraction of cultures
grown in -P+N conditions at 0.01967µg/mL.
Apoptosis was in general lower for UIO 040 extracts than UIO 037 (graphs in Appendix
D). UIO 037 extracts form the -P+N hexane extracts caused the highest level of apoptosis
in this round (403.3 after 6 hours incubation with 100µg/mL dose).
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3.4 Allelopathy experiment
Target cells of Skeletonema pseudocostatum in 96 well plates were treated with six
concentrations (100, 50, 25, 12.5, 6.25, 0%) of two types of extracts (filtrate or lysed cells)
from two P. polylepis strains (UIO 037 and 040, donors) grown under 4 nutrient
conditions (+P+N, -P-N, -P+N, +P-N). Each variable had four replicates and in vivo
fluorescence readings were taken every 24 hours for seven days to track cell density of
Skeletonema. The aim was to assess if the treatments inhibited the growth of Skeletonema
pseudocostatum and if donor algal strain (cell type) or nutrient treatment had an eﬀect on
this. Nonlinear mixed eﬀect modelling was used to consider the influence of random
eﬀects outside of experimental variables to judge if changes in growth were due to the
applied treatments.
3.4.1 Nlme fit of allelopathy experiment data
In order to make compiling data and coding for each model as simple as possible, nutrient
conditions that donor Prymnesium polylepis strains were cultured under were assigned
letters a, b, c, and d (for +P+N, -P-N, -P+N, and +P-N). Concentrations of treatment
were assigned numbers 1-6 in order of decreasing concentration (100, 50, 25, 12.5, 6.25,
and 0%). When reading the graphs (FIGURE 8) below, window a1 corresponds to a
treatment of donor cells grown in +P+N added at a concentration of 100%) to
Skeletonema pseudocostatum target cells. The blue âĂĲfixedâĂİ line is the predicted
growth curve of the target cells without inhibition and any deviation of this pink
âĂĲflaskâĂİ line (actual growth) from this may be interpreted as variation caused by
treatment. The height of these curves is termed the asymptote and the greater the
distance between these is the easiest way to understand any variation. The inflection
point of the curve on the x-axis (xmid) and the slope of the curve (scal) can also be used
to determine any change due to experimental variables but AIC and ANOVA tests on
these showed that they were less significant than asymptotic height.
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Figure 3.11: R plot showing fit of nlme models for Skeletonema pseudocostatum treated with
UIO 037 lysed cells. Letters a-d in each window represent each nutrient treatment (+P+N, -P-N,
-P+N, +P-N). Numbers 1-6 in each window represent concentration of treatment added (100, 50,
25, 12.5, 6.25, and 0%).
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Figure 3.12: R plot showing fit of nlme models for Skeletonema pseudocostatum treated with
UIO 037 filtrate. Letters a-d in each window represent each nutrient treatment (+P+N, -P-N,
-P+N, +P-N). Numbers 1-6 in each window represent concentration of treatment added (100, 50,
25, 12.5, 6.25, and 0%).
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Figure 3.13: R plot showing fit of nlme models for Skeletonema pseudocostatum treated with
UIO 040 lysed cells. Letters a-d in each window represent each nutrient treatment (+P+N, -P-N,
-P+N, +P-N). Numbers 1-6 in each window represent concentration of treatment added (100, 50,
25, 12.5, 6.25, and 0%).
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Figure 3.14: R plot showing fit of nlme models for Skeletonema pseudocostatum treated with
UIO 037 filtrate. Letters a-d in each window represent each nutrient treatment (+P+N, -P-N,
-P+N, +P-N). Numbers 1-6 in each window represent concentration of treatment added (100, 50,
25, 12.5, 6.25, and 0%).
Skeletonema cells experienced most growth inhibition under UIO 040 lysed cell treatment
but due to no obvious pattern of variation between "fixed" and "flask" curves it is hard to
judge if it is a significant result or not. Within treatment types, concentration does not
seem to have a linear eﬀect on growth inhibition with lower concentrations (and even in
controls) sometimes showing more inhibition than at higher concentrations. Donor cells
grown in +P-N (d windows in plots) seem to have a greater growth inhibitory eﬀect but




4.1 High throughput screening for bioactivity
Out of the eleven strains of algae screened, seven showed some activity in the apoptosis
assay (UIO 004 Micromonas pusilla, 007 Pseudoscourfieldia marina, 040 Prymnesium
polylepis, 054 Prymnesium parvum, 226 Dunaliella tertiolecta, 254 Karlodinium micrum,
and 305 Becheleria cincta). In the viability assay the same seven plus one extra (UIO 015
Synecococcus sp.) also inhibited growth in the Jurkat cells. Extracts from UIO 040
Prymnesium polylepis at a dose of 50 µg/mL caused the highest levels of apoptosis out of
any bioassay. In nature this species has been responsible for mass fish kills in nature as
well as haemolytic activity in cod (Edvardsen, Moy, and Paasche 1990), horse
(N. Johansson and E. Granéli 1999), carp (Eschbach et al. 2005), and human erythrocytes
(Meldahl, Edvardsen, and Fonnum 1994) during laboratory tests. Research by the latter
also assessed P. polylepis toxicity by tests with Artemia salina nauplii and the uptake of
neurotransmitters Îş-aminobutyric acid and L-glutamate in rat brain cells (synaptosomes
and synaptic vesicles). All four test methods indicated the haptophyte to be toxic and
that this was due to the synthesis of secondary metabolites as closely related
Chrysochromulina leadbeateri did not test positive for toxicity. These studies show that
Prymnesium polylepis or its extracts can cause eﬀects in organisms of both marine and
terrestrial origin, supporting my findings in the first round of screening.
However, previous history of toxic blooms is not a guarantee of activity in the bioassays
used here. Prymnesium parvum and Karlodinium micrum have both been responsible for
ichthyotoxic blooms in the past Hallegraeﬀ 1993; Deeds et al. 2002 but were not of note in
these tests. After P. polylepis, the microalgae that scored highest in the apoptosis and
viability assays were Micromonas pusilla, Dunaliella tertiolecta, and Biecheleria cincta. As
far as I’m aware results showing this type of bioactivity have not been published before.
For all strains tested, ethyl acetate fractions consistently gave highest activity in the
viability and apoptosis assays. For an extract to progress on to the apoptosis assay, it had
to first show a certain level of activity in the viability tests. Ten of the twelve extracts
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that progressed onto the apoptosis assay were extracted using ethyl acetate (the
remaining two were hexane). No extracts taken with water or ethanol caused enough of a
cytotoxic eﬀect in the viability assays to be considered for the apoptosis bioassay.
4.1.1 Eﬀect of growth conditions and cell life cycle stage on bioas-
say results
Two strains of Prymnesium polylepis were grown under varying nutrient conditions for the
second part of this project. Using TEM, UIO 037 was deemed to be in the alternate life
cycle stage while UIO 040 was authentic (according to Paasche, Edvardsen, and
W Eikrem 1990) and Edvardsen and Paasche 1992). Both were tested using the same
method as before but this time the aim was to discern if any variation in bioactivity was
caused by life cycle stage or growth conditions. The alternate strain of P. polylepis caused
higher inhibition of growth and cytotoxicity in the viability bioassay. Seven out of eight
extracts from UIO 037 caused enough of a response to get reliable IC50 values. For the
authentic strain UIO 040 only one of eight extracts, those from cells grown at full nutrient
conditions, inhibited growth to a degree that IC50 values could be calculated. The IC50 for
strain UiO 040 was the lowest (highest cytotoxicity) of any strain tested with this method,
at 0.019mg/mL. Extracts from alternate Prymnesium polylepis strains cells grown under
phosphorous limited conditions also yielded low IC50 values in this test (0.020mg/mL).
Previous work has also shown that culturing microalgae under nutrient limited conditions
may increase toxicity. Phosphorous limited batch cultures of Prymnesium polylepis were
found to cause higher haemolytic activity than those with suﬃcient nutrients (Edvardsen,
Moy, and Paasche 1990; Meldahl, Edvardsen, and Fonnum 1994). In addition, it has been
shown that nutrient limitation, regardless if it was P or N, leads to higher haemolytic
activity (N. Johansson and E. Granéli 1999). Another study by the same authors on
Prymnesium parvum, a close relative of P. polylepis, also showed increased toxicity when
grown in nutrient limited conditions (N Johansson and E Granéli 1999). Phosphate
limitation increased toxicity up to 20 fold in some studies of P. parvum (Shilo and
Aschner 1953; Dafni, Ulitzur, and Shilo 1972). N and P deficient cultures of Prorocentrum
lima and Dinophysis acuminata exhibited increased production of the toxin okadaic acid
(McLachlan et al. 1994; Sohet et al. 1995; N Johansson, Graneli, et al. 1996). Nutrient
availability seems to be central to the regulation of secondary metabolite production in
phytoplankton and may be used to increase the potential for success in future
bioprospecting projects. Other factors found to activate or promote toxicity in
Prymnesium spp. are the presence of a cofactor (e.g., divalent cations and streptomycin)
and of cationic polyamines, aeration (Shilo 1971) as well as pH, salinity, cell cycle and
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light (Eschbach et al. 2005; Edvardsen and Paasche 1998). The use of these factors to
promote bioactivity could also be of interest in future experiments.
Extracts from UIO 040 Prymnesium polylepis grown at suﬃcient nutrient concentration
were the only for this strain to gain IC50 values. At 0.019mg/mL, these were the lowest of
the whole screening programme but were the only extracts from authentic cells to cause
enough of a response for IC50 to be determined. For the same nutrient conditions and
extraction methods, UIO 040 consistently caused lower caspase 3/7 activity than the
alternate strain UIO 037. In the past, Artemia toxicity tests have shown authentic P.
polylepis to be more toxic than alternate strains (Edvardsen and Paasche 1992). This
result is the opposite of my observations but the Artemia test utilises whole microalgae
cultures while the bioassays in this masters project used fractioned extracts. It is possible
that these diﬀerences in methods may be responsible for the variation in results. As P.
polylepis cultures previously has shown diﬀerent types of toxicity (haemolytic, cytotoxic,
ichthyotoxic activity) it was suggested that there may be diﬀerent toxins produced by this
alga that cause these diﬀerent eﬀects (Edvardsen and Imai 2006). These diﬀerent toxins
causing diﬀerent toxic eﬀects may be produces diﬀerently in the two life cycle stages.
4.2 Eﬀect of strain type and nutrient concentration on
allelopathy
The aim of the allelopathy experiment was to assess the inhibition of Skeletonema
pseudocostatum by treatments using filtrate or lysed cell cultures of Prymnesium polylepis.
S. pseudocostatum with lowest growth rates were those treated with lysed cell cultures
from the authentic UIO 040 strain. This is in conflict with the bioassay results where
alternative strain UIO 037 caused most activity but agrees with previous research on the
variation in toxicity of diﬀerent P. polylepis life cycle stages using the Artemia test
(Edvardsen and Paasche 1992). Allelopathy in Prymnesium polylepis has been researched
on since the toxic bloom 1988. Inhibition of the activity of planktonic bacteria, ciliates
and copepods by P. polylepis has been shown (Nielsen 1990; Tobiesen 1991) as well as
direct eﬀects on other species of microalgae (Schmidt and Hansen 2001). The latter
experiment observed motility in seven dinoflagellates before and after exposure to cultures
of Prymnesium polylepis. Gyrodinium mikimotoi was the only one not to lose motility and
it was concluded that this may be because both target and donor species produce similar
toxins. It is diﬃcult to draw a conclusion on if growth conditions or strain type caused
distinct variations but the overall result seems to agree with previous research in that
Prymnesium polylepis did aﬀect the growth of Skeletonema pseudocostatum.
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4.3 Methodological aspects
While care was taken to avoid errors, reviewing the methods in the writing of this
manuscript has highlighted some possible issues in the methods used. All 900mL cultures
were grown in replicates of two. While all subsamples taken from these cultures were in
triplicate, it would also be recommended to add a third replicate during culturing to help
assess and isolate sources of variation in measurements and limit the eﬀect of random
variation on results found. In the allelopathy experiment, it is possible that lysed cell
treatments from Prymnesium polylepis still contained chlorophyll that underwent
fluorescence in addition to the signal generated by Skeletonema pseudocostatum.
Measuring fluorescence in samples of lysed cell culture alone could confirm or deny if this
had an eﬀect on results. However, on average the fluorescence with S. pseudocostatum
alone (control) did have the same level of fluorescence as the lysed cell samples at the first
measurement on day 0.
4.4 Concluding remarks and future perspectives
The high throughput screening in this study did uncover microalgae that have not been
previously shown to cause bioactivity in cultured cells. These results need to be expanded
upon to investigate if the tested microalgae or their extracts can be used in new future
drugs. Further screening with more Norwegian microalgae in the future could also yield
new sources of metabolites for future drugs. Since nutrient conditions have been shown to
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IMR ½ - algal medium 
 
 (Eppley et al. 1967, modified by E. Paasche, University of Oslo).Without silicate and 
with selenite.   
 
Stock solutions (made with distilled water or MilliQ-water): 
 
 Nitrate:   5 g KNO3 to 100 ml 
  
 Phosphate:         0.68 g KH2PO4 to 100 ml 
  
 Trace metal solution: 6 g Na2EDTA to 1 litre,    
      1 g FeCl3.6 H2O 
    620 mg MnSO4.H2O  
    250 mg ZnSO4.7 H2O 
    130 mg Na2MoO4.2 H2O 
    4 mg CoCl2.6 H2O 
    4 mg CuSO4.5 H2O 
 To avoid precipitation (due to H4EDTA) adjust this solution to pH 8 with 
 concentrated NaOH. 
 
 Vitamin solution: 10 mg tiamine (B-1)  
    0.1 mg cyanocobalamine (B-12) 
    0.1 mg biotine 
    to 100 ml MilliQ water 
 The two latter is added from a more concentrated stock solution due to the small 
 amounts. This solution should be kept in a plastic bottle, preferably at –20°C. 
  
 Selenite solution: 2.63 mg Na2SeO3.5 H2O to 1 litre. 
 
Content in 1L medium of 24‰ salinity (up to 90% seawater is fine): 
 Seawater (34 ‰ S) 700 ml 
 Distilled water                                300 ml 
 Nitrate stock solution                    0.5 ml        (final concentration 250 µM) 
 Phosphate stock solution                        0.5 ml        (final concentration 25 µM) 
 Trace metal-EDTA stock solution           0.5 ml  
 Vitamin stock solution                            0.5 ml 
 Selenite stock solution                             1.0 ml        (final concentration10 nM) 
 
All stock solutions are as described by Eppley et al. 1967, J. Exp. Mar. Biol. Ecol. 1: 
191-208. The stock solutions are prepared with Milli-Q water, they are not autoclaved, 
and kept in the fridge. The vitamin solution can be prepared from stronger stocks that 
are kept in the freezer on plastic flasks. We use half the amounts of stock solutions 
compared to Eppley et al. (0.5 mL per liter instead of 1 mL per litre medium) and call 
the medium IMR 1/2. For flagellates we drop Si (and HCl) and add Se. 
 
The seawater is filtrated (Whatman GF/C) and the medium is autoclaved for 15 min. at 
120°C (110°C is probably sufficient and can be used if you get precipitation at 120°C). 
If distilled water is exchanged with Milli-Q-water make sure that the filter is old and 
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